Pharma and Biotech
By Iain Gilbert
Date: Monday 25 Nov 2024
(Sharecast News) - Aquaculture biotechnology company Benchmark Holdings has disposed of its genetics unit for an enterprise value of up to £260.0m.
By Benjamin Chiou
Date: Monday 22 Jan 2024
(Sharecast News) - Shares in Benchmark Holdings jumped on Monday after the UK-listed aquaculture services group kickstarted a formal sales process
By Josh White
Date: Wednesday 29 Nov 2023
(Sharecast News) - Aquaculture biotechnology company Benchmark reported a 7% increase in revenue from continuing operations in its full-year results on Wednesday, to £169.5m.
Currency | UK Pounds |
Share Price | 21.90p |
Change Today | -1.00p |
% Change | -4.37 % |
52 Week High | 42.00p |
52 Week Low | 17.70p |
Volume | 84,918 |
Shares Issued | 742.42m |
Market Cap | £162.59m |
Beta | 0.12 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
13:56 | 80,000 @ 21.70p |
11:05 | 12 @ 22.20p |
10:28 | 4 @ 22.20p |
09:36 | 4,902 @ 22.20p |
CEO | Trond Williksen |
Chair | Tripp Lane |
You are here: research